*Junko S TAKEUCHI¹, Kento Fukano¹, Masashi Iwamoto^1,2, Senko Tsukuda^1,3, Ryosuke Suzuki¹, Hideki Aizaki¹, Masamichi Muramatsu¹, Takaji Wakita¹, Camille Sureau⁴, Koichi Watashi^6,5,1 (1. Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan, 2. Department of Biology, Faculty of Sciences, Kyushu University, Fukuoka, Japan, 3. Liver Cancer Prevention Research Unit, RIKEN Center for Integrative Medical Sciences (IMS), Wako, Japan, 4. Laboratoire de Virologie Moléculaire, Institut National de la Transfusion Sanguine, INSERM U1134, Paris, France, 5. Department of Applied Biological Sciences, Tokyo University of Science, Noda, Japan, 6. CREST, JST, Saitama, Japan)

*Youki Ueda¹, Weilin Gu¹, Hiromichi Dansako¹, Hironori Nishitsuji², Shinya Satoh¹, Kunitada Shimotohno², Nobuyuki Kato¹ (1. Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2. Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine)

*Tomohisa Tanaka¹, Teruhime Otoguro¹, Hirotake Kasai¹, Atsuya Yamashita¹, Takasuke Fukuhara², Yoshiharu Matsuura², Kohji Moriishi¹ (1. Department of Microbiology, University of Yamanashi, 2. Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University)